We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Sysco
SYY
$39.5B
| $160K | ﹤0.01% |
2,109
-41
| -2% | -$2.98K |
|
1527
Ivanhoe Electric
IE
$1.87B
| $160K | ﹤0.01% |
17,600
-9,400
| -35% | -$65.3K |
|
1528
Greif
GEF
$4.8B
| $160K | ﹤0.01% |
2,456
-11
| -0.4% | -$626 |
|
1529
Sotera Health
SHC
$5.56B
| $159K | ﹤0.01% |
14,309
-174
| -1% | -$2.04K |
|
1530
Coty
COTY
$2.43B
| $159K | ﹤0.01% |
34,201
-478
| -1% | -$2.37K |
|
1531
Mettler-Toledo International
MTD
$28.2B
| $157K | ﹤0.01% |
134
-13
| -9% | -$14.5K |
|
|
HSAI
1532
Hesai Group
HSAI
$2.75B
| $156K | ﹤0.01% |
+7,089
| New | +$125K |
|
1533
Marriott International
MAR
$92.3B
| $154K | ﹤0.01% |
563
-17
| -3% | -$4.26K |
|
1534
EQT Corp
EQT
$34.3B
| $153K | ﹤0.01% |
2,620
-2
| -0.1% | -$108 |
|
1535
Western Digital
WDC
$167B
| $152K | ﹤0.01% |
2,374
+845
| +55% | +$40.2K |
|
1536
NET Power
NPWR
$167M
| $151K | ﹤0.01% |
+61,122
| New | +$128K |
|
1537
Towne Bank
TOWN
$3.45B
| $149K | ﹤0.01% |
4,346
+1,936
| +80% | +$64.6K |
|
1538
Oscar Health
OSCR
$9.27B
| $147K | ﹤0.01% |
6,859
-6,024
| -47% | -$89.6K |
|
|
CON
1539
Concentra Group Holdings
CON
$4.42B
| $146K | ﹤0.01% |
7,118
-48
| -0.7% | -$1.02K |
|
1540
Oportun Financial
OPRT
$344M
| $146K | ﹤0.01% |
20,427
-24,908
| -55% | -$149K |
|
1541
Kelly Services Class A
KELYA
$594M
| $145K | ﹤0.01% |
12,377
+608
| +5% | +$7.17K |
|
1542
Match Group
MTCH
$9.46B
| $144K | ﹤0.01% |
4,667
-2,664
| -36% | -$79.7K |
|
|
GRMN
1543
Garmin
GRMN
$55.9B
| $140K | ﹤0.01% |
670
-5
| -0.7% | -$992 |
|
1544
Capital Bancorp
CBNK
$592M
| $139K | ﹤0.01% |
4,145
+168
| +4% | +$5.16K |
|
1545
Host Hotels & Resorts
HST
$15.3B
| $139K | ﹤0.01% |
9,019
-7,102
| -44% | -$105K |
|
1546
Canadian Natural Resources
CNQ
$103B
| $139K | ﹤0.01% |
4,407
+236
| +6% | +$7.15K |
|
1547
Costamare
CMRE
$1.86B
| $137K | ﹤0.01% |
15,002
-445,222
| -97% | -$3.96M |
|
1548
Cable One
CABO
$128M
| $136K | ﹤0.01% |
1,002
+996
| +16,600% | +$187K |
|
1549
Kyverna Therapeutics
KYTX
$534M
| $135K | ﹤0.01% |
44,000
+8,000
| +22% | +$19.8K |
|
|
SNDK
1550
Sandisk
SNDK
$217B
| $135K | ﹤0.01% |
2,978
-344
| -10% | -$13.2K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.